Scinai Immunotherapeutics Ltd. (SCNI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$7.43M2022: -$7.26M2023: -$9.38M2024: -$6.33M2025: -$6.03M-$6.03M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.03M+4.8%
2024-$6.33M+32.5%
2023-$9.38M-29.1%
2022-$7.26M+2.2%
2021-$7.43M